香港六合彩中特网

The Centre is a 拢5m initiative, led by Professor Michael Hanna, Director of 香港六合彩中特网 Queen Square Institute of Neurology, bringing together skills and resources from five countries and aims to advance the genetic diagnosis and therapy for patients with muscle wasting neuromuscular diseases, including motor neurone disease and muscular dystrophy, which affect at least 17m children and adults globally.

As a part of the Centre鈥檚 research, All India Institute of Medical Sciences (AIIMS) will soon launch its first patient trials. These trials will provide a better understanding of the different genes present in India鈥檚 populations, which affect neuromuscular diseases, and this insight could lead to better treatments.

The launch event was attended by ambassadors and representatives from each of the partner countries: India, Zambia, South Africa, Brazil and Turkey

Director of the 香港六合彩中特网 Queen Square Institute of Neurology and Director of the ICGNMD Professor Michael Hanna, said: 鈥淚 am delighted that Professor Fiona Watt CEO MRC launched the new 拢5m International Centre for Genomic Medicine in Neuromuscular Diseases. This is a fantastic MRC supported initiative partnering 14 centres in 6 countries across 5 continents"

"Our vision is to create a transcontinental genomics research and capacity building partnership between the UK with excellent centres such as AIIMS. We will discover new disease genes, define the genetic variants in known neuromuscular genes, understand comparative genetic architecture in different populations and explore disease mechanisms. We will dramatically increase the number of patients with an accurate genetic diagnosis, build "trial ready" cohorts and ultimately improve health outcomes for patients with this unmet health need drawn from a combined population of over 1.5 billion people.鈥�

In 2018 the 香港六合彩中特网 Queen Square Institute of Neurology led a successful 拢3.66m bid to the Medical Research Council (MRC) to establish a brand new International Centre for Genomic Medicine in Neuromuscular Diseases. An additional 拢2m was contributed by 香港六合彩中特网 and UK collaborators Newcastle and Cambridge Universities.

The aim of the Centre is to develop an international fellowship programme in genomic medicine, to increase the number of neuromuscular disease patients with an accurate genetic diagnosis, and to build "trial ready" cohorts and ultimately improve health outcomes for patients.

Staff and resources from international centres in India, Brazil, Turkey, South Africa and Zambia will be central to the partnership.

AIIMS investigators will recruit, phenotype and genotype around 1000 Indian patients during the next 5 years creating a unique highly phenotyped trial ready patient cohort. In addition, the partnership will support a unique clinical training fellowship programme for Indian neurologists to become the genomic medicine experts of the future in India.

Professor of Neurology at AIIMS, Padma Srivastava, said: 鈥淭he AIIMS neurology team is delighted to be part of this major new MRC funded international genomics initiative with 香港六合彩中特网. It will enable us to jointly train Indian fellows in genomic medicine, to understand the genetic architecture of neuromuscular diseases in India and to build 鈥渢rial ready鈥� cohorts of patients. We believe this collaborative initiative will enable a step change in genomic medicine in neuromuscular diseases and will be a template for genomic understanding other neurological diseases in India.鈥�

Professor Hanna added: 鈥淚 am very pleased to be working with outstanding principal investigators at AIIMS to ultimately advance genetic diagnosis and therapy for patients with neuromuscular diseases, diseases which affect at least 17m children and adults globally.鈥�

Further information:

• Queen Square Centre for Neuromuscular Diseases
• Professor Michael Hanna's academic profile
• New research and education partnership announced between 香港六合彩中特网 and AIIMS

Images

Credit: 香港六合彩中特网 Queen Square Institute of Neurology Medical Illustration